menu
    • menu

    Company profile for Yuyu Pharma

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Yuyu Pharma (KRX 000220) was founded in 1941 and is a healthcare company located in Korea. The company is publicly traded since 1975. It manufactures, distributes, and does marketing for pharmaceutical products, medical devices, and medical foods in South Korea and Southeast Asia. The key therapeutic markets are CNS, Osteoporosis, Respiratory, and Urology. The R&D center has previously developed two unique improved medicines, ...
    Yuyu Pharma (KRX 000220) was founded in 1941 and is a healthcare company located in Korea. The company is publicly traded since 1975. It manufactures, distributes, and does marketing for pharmaceutical products, medical devices, and medical foods in South Korea and Southeast Asia. The key therapeutic markets are CNS, Osteoporosis, Respiratory, and Urology. The R&D center has previously developed two unique improved medicines, Maxmarvil® for patients with osteoporosis and YUCLID® for anti-thrombosis.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Yuyu Pharmakorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    Yuyu Building, 197 Dongho-ro, Jung-gu, Seoul, Republic of Korea
    Telephone
    Telephone
    02-2253-6600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.yuyu.co.kr/en/main/main.do
    Linkedin
    Linkedin
    https://www.linkedin.com/company/yuyu-pharma/?originalSubdomain=kr
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Yuyu Pharma to attend 'CPHI Worldwide 2023'
    Yuyu Pharma to attend 'CPHI Worldwide 2023'

    18 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/yuyu-pharma-to-attend-cphi-worldwide-2023-301959829.html

    PR NEWSWIRE
    18 Oct 2023
    Share Share
    Yuyu Pharma, Dry Eye Pipeline MOA & Pre-clinical Results Published
    Yuyu Pharma, Dry Eye Pipeline MOA & Pre-clinical Results Published

    27 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/yuyu-pharma-dry-eye-pipeline-mechanism-of-action-and-pre-clinical-results-published-301809197.html

    PR NEWSWIRE
    27 Apr 2023
    Share Share
    Yuyu Pharma unveiled the results of its MOA and head-to- head studies
    Yuyu Pharma unveiled the results of its MOA and head-to- head studies

    27 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/yuyu-pharma-unveiled-the-results-of-its-mechanism-of-action-and-head-to--head-studies-for-its-dry-eye-treatment-peptide-301809213.html

    PR NEWSWIRE
    27 Apr 2023
    Share Share
    Yuyu Pharma Plans to Enter the U.S. and European Markets for Hair Loss Treatment
    Yuyu Pharma Plans to Enter the U.S. and European Markets for Hair Loss Treatment

    29 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/yuyu-pharma-plans-to-enter-the-us-and-european-markets-for-hair-loss-treatment-301688588.html

    PRNEWSWIRE
    29 Nov 2022
    Share Share
    Yuyu Pharma attendance at European Pharmaceutical Conference
    Yuyu Pharma attendance at European Pharmaceutical Conference

    03 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/yuyu-pharma-attendance-at-european-pharmaceutical-conference-301667035.html

    PRNEWSWIRE
    03 Nov 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search